Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.

ABSTRACT:

Importance

The appropriate target of glycemic control in diabetic kidney disease is unclear.

Objective

To investigate optimal on-treatment glycemic levels associated with slowing of diabetic kidney disease progression.

Design, setting, and participants

This retrospective cohort study was conducted using nationwide Korean cohorts from the National Health Information Database from 2005 to 2019. Included individuals were adults with diabetes using antihyperglycemic agents with and without chronic kidney disease (CKD) identified from participants aged 40 to 74 years in a nationwide health screening survey conducted from 2009 to 2010. Data were analyzed from October 2020 through March 2021.

Exposure

On-treatment fasting blood glucose (FBG) level.

Main outcomes an

SUBMITTER: Jung HH 

PROVIDER: S-EPMC8482057 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature